Optimizing the Temperature for Embryo Culture in In Vitro Fertilization
1 other identifier
interventional
55
1 country
2
Brief Summary
Many human and animal studies over the past 40 years have revealed that ovaries and Fallopian tubes have a lower temperature than core body temperature, especially around the time of ovulation and early embryo development. Whether average core body temperature, 37 degrees Celsius, is ideal temperature for culture has not been prospectively evaluated. The purpose of this study is to determine whether lowering the incubator temperature by 1 degree Celsius will result in meaningful improvements in embryo development and pregnancy rates. Patients participating in this study will undergo routine in vitro fertilization (IVF) stimulation. Following egg retrieval, patients with at least 8 mature eggs will have those eggs divided randomly into two groups. Both groups will then under ICSI (intra-cytoplasmic sperm injection) to fertilize the eggs. The groups will randomly be assigned to control or study condition. The control condition group will be cultured at 37 degrees Celsius, the current standard of care. The study group will be cultured at 36 degrees Celsius. All other culture conditions will be kept identical and embryos will be assessed on day 3 and day 5 of development. On day 5, all well-developed blastocysts will undergo biopsy for Comprehensive Chromosomal Screening (CCS), which will evaluate the chromosomal normalcy of the embryo . Patients will undergo transfer on the morning of day 6 and the highest quality, chromosomally normal embryo from each group (the 36 degree cultured embryos and the 37 degree cultured embryos) will be transferred. If only 1 embryo is available for transfer, the patient will have a single embryo transfer. All embryos available for cryopreservation will undergo biopsy for CCS before being frozen. Some arrested embryos from each temperature group will also undergo genetic analysis to evaluate chromosomal normalcy or mosaicism. The female patient will undergo a blood draw at 9 weeks gestation and buccal swabs will be obtained from the infant(s) after birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 3, 2012
CompletedFirst Posted
Study publicly available on registry
January 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedMarch 26, 2015
March 1, 2015
2 years
January 3, 2012
March 25, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Useable Blastocyst Formation Rate
Proportion of mature eggs developing into expanded blastocysts (Gardner grade 3-6) of sufficient quality to transfer or cryopreserve will be documented for each group (36 degree and 37 degree group).
approximately 1 week
Secondary Outcomes (6)
Fertilization rate
approximately 2 days
Cleavage Rate
approximately 1 week
Blastocyst Formation Rate
approximately 1 week
Implantation Rate
approximately 2 weeks
Aneuploidy Rate
approximately 1 month
- +1 more secondary outcomes
Study Arms (2)
36 degree group
EXPERIMENTAL36 degrees Celsius for the incubators is the experimental condition in this study.
37 degree group
NO INTERVENTION37 degrees Celsius is the standard incubator temperature for the culture of embryos.
Interventions
Embryos in this group will be cultured in incubators set to 36 degrees Celsius.
Eligibility Criteria
You may qualify if:
- No more than 1 prior failed cycle at RMA NJ facility; up to 2 prior failed cycles at another facility pending investigator review
- Female partner between 18 and 41 at onset of IVF cycle
- Normal day 3 FSH (\< or = 12) in RMA NJ laboratory
- Basal antral follicle count of at least 10
- Male partner with greater than 100,000 total motile spermatozoa per ejaculate (donor sperm is ok)
- BMI \< or = 32 kg/m2
You may not qualify if:
- Diagnosis of chronic anovulation (cycles occuring typically less often than every 90 days)
- Use of testicular aspiration or biopsy procedures to obtain sperm
- Unevaluated ovarian mass or diagnosis of surgically-confirmed stage IV endometriosis
- Presence of hydrosalpinges that communicate with the uterine cavity
- History of endometrial insufficiency
- Any contraindication to undergoing IVF or gonadotropin stimulation
- Prior poor fertilization rate- less than 50% of mature eggs
- Prior poor blastulation rate- less than 10% of 2PNs (day 1 embryos)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Reproductive Medicine Associates of New Jersey
Morristown, New Jersey, 07960, United States
Reproductive Medicine Associates of Pennsylvannia
Allentown, Pennsylvania, 18104, United States
Related Publications (1)
Hong KH, Lee H, Forman EJ, Upham KM, Scott RT Jr. Examining the temperature of embryo culture in in vitro fertilization: a randomized controlled trial comparing traditional core temperature (37 degrees C) to a more physiologic, cooler temperature (36 degrees C). Fertil Steril. 2014 Sep;102(3):767-73. doi: 10.1016/j.fertnstert.2014.06.009. Epub 2014 Jul 17.
PMID: 25044079DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard T Scott, MD
Reproductive Medicine Associates of New Jersey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2012
First Posted
January 9, 2012
Study Start
January 1, 2012
Primary Completion
January 1, 2014
Study Completion
July 1, 2014
Last Updated
March 26, 2015
Record last verified: 2015-03